Ensitrelvir as a potential treatment for COVID-19
MW McCarthy - Expert Opinion on Pharmacotherapy, 2022 - Taylor & Francis
Introduction First-generation therapeutics have improved clinical outcomes in patients
infected with SARS-CoV-2. However, viral evolution has produced variants and subvariants …
infected with SARS-CoV-2. However, viral evolution has produced variants and subvariants …
VV116 as a potential treatment for COVID-19
MW McCarthy - Expert Opinion on Pharmacotherapy, 2023 - Taylor & Francis
Introduction VV116 is a chemically-modified version of the antiviral remdesivir with oral
bioavailability and potent activity against SARS-CoV-2. Areas Covered The optimal …
bioavailability and potent activity against SARS-CoV-2. Areas Covered The optimal …
An overview of repurposed drugs for potential COVID-19 treatment
K Govender, A Chuturgoon - Antibiotics, 2022 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on
healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the …
healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the …
Interferon lambda as a potential treatment for COVID-19
MW McCarthy - Expert Opinion on Biological Therapy, 2023 - Taylor & Francis
Introduction Pegylated interferon lambda substantially reduced the risk of COVID-19-related
hospitalizations or emergency room visits in a recent phase 3, multi-center, randomized …
hospitalizations or emergency room visits in a recent phase 3, multi-center, randomized …
SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?
The coronavirus disease (COVID)-19 has turned into a pandemic causing a global public
health crisis. While acute COVID-19 mainly affects the respiratory system and can cause …
health crisis. While acute COVID-19 mainly affects the respiratory system and can cause …